Mark Kirschbaum Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

Mark Kirschbaum is Chief Medical Officer of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 31,200 shares of CYCC, which is worth approximately $11,232. The most recent transaction as insider was on Jan 31, 2023, when has been sold 31,200 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.2K
0% 3M change
0% 12M change
Total Value Held $11,232

Mark Kirschbaum Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
BUY
Grant, award, or other acquisition
-
31,200 Added 50.0%
31,200 Common Stock
MK

Mark Kirschbaum

Chief Medical Officer
Berkeley Heights, NJ

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC